Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus

Renal cell carcinoma with level IV tumor thrombus is a condition necessitating aggressive surgical management. Many solid organ malignancies often benefit from neoadjuvant treatments for tumor debulking and improvement of surgical outcomes. However, neoadjuvant treatments for renal cell carcinoma ha...

Full description

Bibliographic Details
Main Authors: Viraj A. Master, Benjamin N. Schmeusser, Adeboye O. Osunkoya, Arnold R. Palacios, Eric Midenberg, Lauren Yantorni, Kenneth Ogan, Mehmet A. Bilen
Format: Article
Language:English
Published: Innovative Healthcare Institute 2023-01-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
neoadjuvant
renal cell carcinoma
tumor thrombus
systemic therapy
nivolumab
ipilimumab
combination therapy
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-22-16

Internet

https://jipo.org/doi/pdf/10.36401/JIPO-22-16

Similar Items